Postdoctoral Fellow: Dr Eirini Kontou
This study will explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used for people with aphasia. Information will also be collected to design a future large-scale trial evaluating this approach.
Launched today, an NIHR review of research evidence into the organisation and quality of stroke service is available to download from the NIHR website.
People with aphasia are at risk of becoming depressed and isolated. However, due to their language difficulties they are often excluded from stroke research exploring effective interventions. This research will explore whether an existing therapy, Solution Focused Brief Therapy (SFBT), can be used with people with aphasia.
Beyond impaired language function, people with aphasia report a range of psychosocial health problems which negatively affect their wellbeing, including reduced confidence and social isolation. These psychosocial problems are not adequately addressed by healthcare services.
This week we ran our first dedicated Service User Review Panel (SURP) training day, which was an opportunity for SURP members new and longer serving to receive the latest guidance in lay review, and to network too.
Stroke survivors often have very individual hopes for the future, in terms of the goals they would like to achieve. This research will develop and test a Goal setting and Action Planning (G-AP) approach to achieving personal goals through community rehabilitation.
Information about our Service User Review Panel.
This research programme aims to understand how stroke survivors can be supported through the process of working towards their personal goals by working in collaboration with their community rehabilitation teams.
Early Supported Discharge (ESD) is the discharge of a stroke patient from hospital to their own home, co-ordinated by a team of therapists, nurses and a doctor. A number of ESD services have been set up across England. Do these services offer the same benefits to patients as those identified in clinical trials?